简介:【摘要】:目的 观察分析联合应用 乙酰螺旋霉素与口泰漱口液治疗牙龈出血患者的临床效果,为临床上选择合理的药物提供依据。方法 将 我院 2018 年 1 月至 2018 年 12 月收治的牙龈出血患者 104 例 采用随机数字表法分为两组:对照组( n=52 ) 和研究组( n=52 ) 。对照组患者应用乙酰螺旋霉素片进行治疗,研究组联合应用乙酰螺旋霉素片与口泰漱口液进行治疗。观察比较两组患者临床疗效以及治疗满意度。结果 研究组患者的临床治疗总有效率为 96.15% ,明显高于对照组的 82.69% ,差异有统计学意义( P<0.05 )。研究组患者的治疗满意度为 98.08% ,明显高于对照组的 80.77% ,差异有统计学意义( P<0.05 )。 结论 乙酰螺旋霉素与口泰漱口液联合应用治疗牙龈出血患者可以取得满意的临床疗效,从而提供患者的治疗满意度,临床推广应用的价值较高。
简介:摘要:目的:探究多烯磷脂酰胆碱治疗方案用在妊娠期肝内胆汁淤积症患者中的效果及价值。方法:2021年5月-2022年7月,选择200例本院收治的妊娠期肝内胆汁淤积症患者,随机分2组,各100例,对照组:常规药物治疗,试验组:多烯磷脂酰胆碱治疗,比较症状消失时间、血液生化指标、妊娠结局。结果:对比症状消失时间,试验组短于对照组,P<0.05;血液生化指标对比,试验组优于对照组,P<0.05;统计不良妊娠结局,即早产、羊水污染、剖宫产、新生儿窒息发生率,试验组均少于对照组,P
简介:摘要:目的 对比观察在对产后出血进行治疗的过程中,应用卡前列甲酯栓与缩宫素的效果差异,并探讨护理对策。方法 整理本院患者病历,将2020年8月-2021年8月时间段内接受治疗的产后出血患者资料抽取68份进行分析,患者随机均分2组各34例,参照组为缩宫素治疗患者,研究组为卡前列甲酯栓与缩宫素联合治疗患者,对比不同方案下患者治疗的差异。结果 研究组患者均出血量更低、有效性更高,对比有统计差异(P<0.05)。结论 在对产后出血进行治疗的过程中,应用卡前列甲酯栓与缩宫素联合治疗能够获得较高的有效性,辅以优质护理措施,能够进一步保证患者的安全性。
简介: 【摘 要】目的:观察单硝酸异山梨酯注射液对心肌梗死后并发症的临床疗效。方法:将 82例患者随机分为治疗组与对照组,每组 41例,治疗组使用单硝酸异山梨酯注射液 20mg混入 5%葡萄糖液 250ml中,静脉滴注,一日一次,连续使用 15天。对照组使用参麦注射液 60ml 混入 5%葡萄糖注射液 250ml中,静脉滴注,一日一次,并口服硝酸异山梨酯片 10mg,一日三次。结果:两组中,治疗组 41例,病死率为 4.8%;对照组 41例,病死率 12.2%。治疗组 41例,心绞痛发生率为 8%,心律失常发生率 5%;对照组 41例,心绞痛发生率为 39%。治疗组治疗效果明显高于对照组。结论:单硝酸异山梨酯注射液,能够有效的防治心肌梗死后并发症,防治冠心病心绞痛、心律失常等。具有起效快、疗效高、安全、不良反应少等特点,是一种安全有效的心血管药物,已成为治疗心血管疾病中的基本药物,在心肌梗塞后并发症中的常规用药。 【关键词】单硝酸异山梨酯注射液;心肌梗死;并发症;疗效 [Abstract] Objective: To observe the clinical effect of Isosorbide Mononitrate Injection on complications after myocardial infarction. Methods: 82 patients were randomly divided into treatment group and control group, 41 cases in each group. The treatment group was given Isosorbide Mononitrate Injection 20mg mixed with 250ml 5% glucose solution, intravenous drip, once a day, for 15 consecutive days. The control group was given Shenmai injection 60ml mixed with 250ml 5% glucose injection, intravenous drip, once a day, and oral isosorbide nitrate tablets 10mg, three times a day. Results: in the two groups, 41 cases in the treatment group, the mortality rate was 4.8%; 41 cases in the control group, the mortality rate was 12.2%. The incidence of angina pectoris and arrhythmia was 8% and 5% in the treatment group and 39% in the control group. The treatment effect of the treatment group was significantly higher than that of the control group. Conclusion: Isosorbide Mononitrate Injection can effectively prevent and treat the complications after myocardial infarction, coronary heart disease, angina pectoris and arrhythmia. It is a safe and effective cardiovascular drug. It has become the basic drug in the treatment of cardiovascular diseases and the conventional medication in the complications after myocardial infarction.
简介: 【摘 要】目的:分析胃肠镜检查术应用依托咪酯复合丙泊酚静脉麻醉的效果。方法:本次研究对象为本院在 2018年 7月 -2019年 7月间接受胃肠镜检查的患者,共 90例,根据住院顺序等分成 A组和 B组, A组实施依托咪酯麻醉, B组实施依托咪酯联合丙泊酚麻醉,对 2组患者体动、肌痉挛及检查时间、清醒时间、术中依托咪酯用量进行比较。结果: B组体动、肌痉挛的发生率低于 A组 ;检查与清醒时间相比, 2组无差异( P>0.05),依托咪酯用量相比, B组明显低于 A组( P<0.05)。结论:胃肠镜检查术中运用依托咪酯复合丙泊酚静脉麻醉,有着显著安全性,可以使体动、肌痉挛等不良反应的发生率有效减少,减少依托咪酯的用量,从而确保手术的顺利开展。 【关键词】依托咪酯 ;丙泊酚 ;麻醉 ;胃肠镜检查术 ;分析 Objective: to analyze the effect of intravenous anesthesia with etomidate combined with propofol in gastroenteroscopy. Methods: 90 patients who underwent gastroenteroscopy in our hospital from July 2018 to July 2019 were divided into group A and group B according to the order of hospitalization. Group A was given etomidate anesthesia, and group B was given etomidate combined with propofol anesthesia. The body movement, muscle spasm, examination time, awake time and intraoperative etomidate dosage were compared between the two groups. Results: the incidence of body movement and muscle spasm in group B was lower than that in group A; there was no difference between the two groups in terms of examination and awake time (P > 0.05), and the dosage of etomidate in group B was significantly lower than that in group A (P < 0.05). Conclusion: the application of etomidate combined with propofol intravenous anesthesia in gastroenteroscopy has significant safety, which can effectively reduce the incidence of body movement, muscle spasm and other adverse reactions, reduce the dosage of etomidate, so as to ensure the smooth operation.
简介:[摘要] 目的:探究阿替普酶对急性脑梗死患者临床疗效及血清炎症因子的影响。方法:选取2022年3月至2023年3月期间于我院收治的急性脑梗死患者82例作为本次研究对象,根据入院先后顺序将所有患者分为治疗组(41例)和对照组(41例)。其中给予对照组患者急性脑梗死替罗非班治疗,治疗组患者则在对照组的基础上采用阿替普酶治疗。对比两组急性脑梗死患者的临床疗效状况。结果:通过对比得出,治疗组患者的总效率高于对照组(P<0.05);2组在治疗后的S-100蛋白β亚基(S-100β)、神经元特异性烯醇化酶(NSE)水平均下降,神经生长因子(NGF)水平升高,且治疗组S-100β、NSE水平均比对照组低(P<0.05);2组在治疗后2周血清炎症因子评分明显低于治疗前(P<0.05)。结论:阿替普酶能有效降低急性脑梗死患者血清NSE和S-100β水平,改善神经功能,并抑制其炎症反应。
简介: 【摘要】 目的 分析替诺福韦酯对核苷(酸)耐药的慢性乙型肝炎伴肝衰竭患者的临床效果。方法 60例对核苷(酸)耐药的慢性乙型肝炎伴肝衰竭患者, 随机分为对照组和观察组, 每组30例。对照组患者给予常规内科治疗, 观察组患者在对照组基础上给予富马酸替诺福韦二吡呋酯片治疗。观察比较两组患者乙肝病毒的脱氧核糖核酸(HBV-DNA)转阴率、治疗前后国际标准化比值(INR)、肝脏生化指标[总胆红素(TBIL)、总胆固醇(TC)、白蛋白(ALB)]、HBV-DNA载量及病死情况。結果 观察组患者HBV-DNA转阴率为50.00%(15/30), 高于对照组的13.33%(4/30), 差异具有统计学意义(P
简介: 【摘要】 目的 进一步研究干扰素体外释放酶联免疫检验技术在结核病诊断中的优势, 为未来进一步提高结核病检出率奠定基础。方法 138 例患者, 分别接受结核菌素皮肤过敏试验与干扰素体外释放酶联免疫检验。比较两种检查方法诊断结核病的灵敏度、特异度 ; 不同结核病患者干扰素体外释放酶联免疫检验诊断准确率。结果 138 例患者, 病理确诊结核病 42 例, 非结核病 96 例。干扰素体外释放酶联免疫检验诊断结核病的灵敏度为 85.71% ( 36/42 )、特异度为 90.63% ( 87/96 ), 均高于结核菌素皮肤过敏试验的 66.67% ( 28/42 )、 80.21% ( 77/96 ), 差异具有统计学意义( P<0.05 )。肺结核患者 27 例, 肺外结核患者 15 例。肺外结核患者干扰素体外释放酶联免疫检验诊断准确率为 100.00% , 高于肺结核患者的 77.78% , 差异具有统计学意义( P<0.05 )。结论 干扰素体外释放酶联免疫检验方法满足结核病临床诊断的需求, 该诊断方法具有更高的阳性检出率, 并且还具有操作步骤简单、结果精准等优点, 能够减少误诊、漏诊等情况发生, 为结核病的早期预防、早期治疗奠定基础, 因此值得在临床上做进一步推广。 【关键词】 干扰素体外释放酶联免疫检验技术 ; 结核病 ; 结核菌素皮肤过敏试验 [Abstract] objective to further study the advantages of in vitro release of interferon enzyme-linked immunosorbent assay (ELISA) in the diagnosis of tuberculosis and lay a foundation for further improving the detection rate of tuberculosis in the future. Methods 138 patients were tested by tuberculin skin allergy test and interferon releasing enzyme-linked immunosorbent assay. The sensitivity and specificity of the two methods were compared, and the diagnostic accuracy of ELISA for ifn-ifn-release in vitro in different tuberculosis patients was compared. Results of the 138 patients, 42 were confirmed by pathology and 96 were non tuberculosis. The sensitivity and specificity of ELISA were 85.71% (36 / 42) and 90.63% (87 / 96) respectively, which were higher than 66.67% (28 / 42) and 80.21% (77 / 96) of tuberculin skin allergy test. There were 27 cases of tuberculosis and 15 cases of extrapulmonary tuberculosis. The diagnostic accuracy of ELISA was 100.00%, higher than that of 77.78% (P < 0.05). Conclusion the ELISA method of interferon releasing in vitro can meet the needs of clinical diagnosis of tuberculosis. This method has higher positive detection rate, simple operation steps and accurate results, which can reduce misdiagnosis and missed diagnosis and lay a foundation for early prevention and treatment of tuberculosis, Therefore, it is worthy of further promotion in clinical practice.
简介: 【摘要】 目的 观察瑞替普酶溶栓治疗急性ST段抬高型心肌梗死患者的疗效及安全性。方法 将68例急性ST段抬高型心肌梗死患者随机分为两组,瑞替普酶组34例,以瑞替普酶20 mu间隔30 min,分2次静脉推注溶栓;尿激酶组34例,以尿激酶150U,30 min静脉滴注溶栓。比较两组的再通率、出血并发症的发生率及过敏反应。结果 瑞替普酶组的梗死相关动脉总开通率明显高于尿激酶组,有明显差异(PO.05)。结论 瑞替普酶是治疗急性心肌梗死安全有效的溶栓药物。
简介:【摘要】目的 分析富马酸替诺福韦二吡呋酯联合扶正柔肝方在乙肝肝纤维化治疗中的应用效果。方法 选取2019年3月-2019年12月本院80例乙肝肝纤维化患者,随机分为对照组(富马酸替诺福韦二吡呋酯)与观察组(富马酸替诺福韦二吡呋酯联合扶正柔肝方),对比两组治疗效果。结果 TBIL、ALB、ALT、AST、HA、LN、PC-Ⅲ、Ⅳ-C方面,观察组较对照组优(P